From spaceflight to high-throughput studies, evidence supports greater use of organ chips, but regulatory ambiguity and ...

The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that despite seasonally updated ...

Traditional animal models and simplified cell cultures often fail to capture human biology, limiting progress in biomedical research and drug development. Emerging microfluidic "Organ-on-Chip" ...

insights from industryJim CorbettCEOEmulate, Inc. In this interview, NewsMedical speaks with Jim Corbett, CEO of Emulate, Inc., about the development and impact of the AVA Emulation System and how it ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration’s (FDA) newly announced plan to reduce reliance on ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...

(BOSTON) — Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

Linda Griffith, bioengineer and director of MIT's Center for Gynepathology Research, is working to grow human tissue on bits of plastic to better understand and treat systemic gynecological diseases, ...